Pharmaceutical company BioNTech and its US partner Pfizer say they will provide 100 million more doses of their coronavirus vaccine to the European Union this year.
The two companies said Monday that the 27-nation group's executive Commission exercised an option to purchase the additional doses, bringing the total number of shots to be delivered to the EU in 2021 to 600 million.
The announcement offers a much-needed boost to the EU's sluggish and much-criticised vaccine rollout.
Sean Marett, the chief business officer of BioNTech, said deliveries of the company's mRNA-based vaccine this year will cover two-thirds of the EU population.
The bloc has so far administered about 105 million shots to its population of some 450 million. Most vaccines require two shots to provide full immunisation.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)